4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-22-004893
Options or other derivatives
- SVP of Research, CSO acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Magnani John L. · SVP of Research, CSO
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-21 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +100,000 | 100,000 | D |
| 2022-01-21 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +25,000 | 25,000 | D |
Loading xslF345X03/doc4.xml…